Arcutis Biotherapeutics, Inc.
ARQT
$20.69
-$0.55-2.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.08% | -3.06% | -42.20% | -47.35% | -50.95% |
| Total Receivables | 69.03% | 100.13% | 91.48% | 145.76% | 129.89% |
| Inventory | 125.06% | 55.82% | 59.96% | 17.61% | 25.42% |
| Prepaid Expenses | 1.74% | -5.64% | 16.66% | -25.93% | 21.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 112.13% | 22.63% | 0.19% | 226.01% | 1,122.20% |
| Total Current Assets | 35.34% | 22.46% | -17.58% | -23.43% | -30.85% |
|
|
|||||
| Total Current Assets | 35.34% | 22.46% | -17.58% | -23.43% | -30.85% |
| Net Property, Plant & Equipment | 61.80% | 84.03% | 78.13% | -11.05% | -8.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.64% | 56.26% | 57.02% | 162.86% | 164.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 285.23% | 138.09% | 0.00% | 0.17% | 0.00% |
| Total Assets | 33.68% | 24.10% | -15.18% | -20.76% | -28.09% |
|
|
|||||
| Total Accounts Payable | -25.41% | -11.90% | -70.01% | 89.88% | 89.14% |
| Total Accrued Expenses | 108.27% | 73.69% | 76.12% | 106.08% | 95.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 844.18% | -- | -99.00% | 28.70% | 11.38% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 79.09% | 60.27% | -42.14% | 102.40% | 92.63% |
|
|
|||||
| Total Current Liabilities | 79.09% | 60.27% | -42.14% | 102.40% | 92.63% |
| Long-Term Debt | -5.71% | 0.71% | 2.29% | -47.48% | -46.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 124.40% | 105.54% | 90.33% | -29.01% | -26.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.72% | -24.39% | -14.29% | 85.57% | 17.65% |
| Total Liabilities | 34.21% | 27.25% | -24.16% | -17.37% | -20.56% |
|
|
|||||
| Common Stock & APIC | 3.86% | 3.76% | 3.66% | 3.63% | 3.82% |
| Retained Earnings | -0.21% | -1.44% | -3.99% | -8.72% | -12.75% |
| Treasury Stock & Other | -267.14% | -528.57% | -111.63% | 88.10% | -5.26% |
| Total Common Equity | 32.94% | 20.27% | 0.91% | -25.45% | -36.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.94% | 20.27% | 0.91% | -25.45% | -36.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.94% | 20.27% | 0.91% | -25.45% | -36.58% |
|
|
|||||